z-logo
open-access-imgOpen Access
Effectiveness of total-contact cast immobilization: Overview of randomized clinical studies conducted in foreign clinics and originaldata
Author(s) -
Олег Виктовович Удовиченко,
Евгения Викторовна Бублик,
Надежда Викторовна Максимова,
Кира Юрьевна Пряхина,
Ольга Сергеевна Ермолаева,
Питер Спруит,
Г. Р. Галстян
Publication year - 2010
Publication title -
saharnyj diabet
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 12
eISSN - 2072-0378
pISSN - 2072-0351
DOI - 10.14341/2072-0351-5674
Subject(s) - medicine , diabetic foot , surgery , randomized controlled trial , diabetic ulcers , foot (prosody) , diabetes mellitus , linguistics , philosophy , endocrinology
Aim. To evaluate effectiveness of unloading immobilization bandages manufactured from Soft Cast and Scotchcast materials. Materials and methods. The study included all patients (n=39) with diabetic foot ulcers treated with the use of total-contact cast technology (TCC)from 01.10.2007 to 01.03.2009. 31 patients presented with neuropathic foot ulcers and 8 with neuroischemic ulcers (in the absence of critical foot ischemia).26 and 13 were managed using non-removable and removable casts respectively. All were given standard local treatment of ulcers, supplementedby antibacterial therapy in 20 patients. Results. Treatment resulted in the healing of ulcers in 31 (79%) patients during 40.5?32.9 days (M?SD) (median 27, min 7, max 11 days). In 28(72%) of them, healing required 12 weeks to complete. TCC had to be removed in 8 (21%) patients because of low efficiency or complications. Newulcers or abrasions related to the use of TCC developed in 10 patients but treatment was discontinued only in one of them. We distinguished a subgroupof 12 patients comparable in terms of major characteristics (plantar stage 1A and 2A neuropathic ulcers according to Texas University classification)and unloading method (non-removable cast throughout the treatment period) with patients included in earlier randomized studies. In this subgroup,healing of 100% ulcers was completed within 12 weeks (median 22 (13-74) days). Conclusion. 1. Efficiency of TCC in our practice is comparable with that in earlier publications. 2. The use of TCC is indicated not only for thetreatment of uninfected plantar neuropathic ulcers but also in some cases of neuroischemic and non-plantar ulcers. 3. Skin lesions from TCC is oflittle clinical significance and can be avoided by specialized education of the medical personnel involved in TCC manufacture.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here